P3 Health Partners Inc. (PIII)
NASDAQ: PIII
· Real-Time Price · USD
6.47
-0.21 (-3.14%)
At close: Jun 16, 2025, 3:58 PM
-3.14% (1D)
Bid | 6 |
Market Cap | 21.14M |
Revenue (ttm) | 1.49B |
Net Income (ttm) | -137.63M |
EPS (ttm) | -52.42 |
PE Ratio (ttm) | -0.12 |
Forward PE | -0.47 |
Analyst | Hold |
Ask | 6.85 |
Volume | 2,077 |
Avg. Volume (20D) | 12,692 |
Open | 6.42 |
Previous Close | 6.68 |
Day's Range | 6.42 - 6.65 |
52-Week Range | 6.20 - 33.30 |
Beta | 0.83 |
About PIII
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PIII
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PIII stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+17.73%
P3 Health Partners shares are trading higher. The ...
Unlock content with
Pro Subscription
7 months ago
-35.99%
P3 Partners shares are trading lower after the company reported worse-than-expected Q3 financial results.

2 months ago · seekingalpha.com
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call TranscriptP3 Health Partners Inc. (NASDAQ:PIII ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Ryan Halsted - IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Med...

2 months ago · businesswire.com
P3 Health Partners Announces Fourth Quarter and Full Year 2024 ResultsHENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financ...